Andrew Cutbert

Dr Cuthbert is working to improve the understanding of biological mechanisms that underlie major psychiatric disorders such as autism, schizophrenia and ADHD. He is a member of a large team of researchers investigating the impacts of genetic changes associated with learning disability, neuropsychiatric disorders and developmental delay. This work is directly coupled with translational neuroscience research to redefine the nosology psychiatric disorders, transforming patient diagnosis and treatment.

 

Andrew has provided expert knowledge to the Chief Scientific Officer (England) on rare genetic disorders where there is significant risk for psychiatric comorbidity. Furthermore, he is helping NHS partners to develop recruitment strategies for patients with intellectual disability and comorbid psychotic disorders to improve access to diagnostic whole genome sequencing.

 

 

Andrew is working with third sector partners to improve access to mental health services for young people with neurodevelopmental disabilities. To support this he is working with specialist charities on the development of expert informational resources for families and healthcare professionals about co-occurring mental health problems in children with genetic disorders of learning and development.

​